每年專案
指紋
查看啟用 血液腫瘤科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
概要
專案
- 19 已完成
-
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究－靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果(3/3)
Hsieh, Y.-Y. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
-
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究-靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果 (2/3)
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217)
Chiang, N. J., Su, Y. Y., Ho, I. W., Bai, L. Y., Li, C. P., Chen, J. S., Hsiao, C. F., Tsou, H. H., Hsu, C., Chiu, T. J., Hsieh, Y. Y., Rau, K. M., Ho, C. L., Shan, Y. S. & Chen, L. T., 2月 25 2026, 於: European Journal of Cancer. 235, 116229.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines
Yen, C. C., Wu, I. C., Yu, C. C., Chen, M. H., Chiang, N. J., Fang, W. L., Chen, K. H., Chen, C. C., Hong, T. C., Chen, Y. C., Wong, M. W., Chan, D. C., Chen, I. S., Chen, Y. Y., Liu, Y. W., Wu, J. M., Chou, W. C., Yang, C. K., Hsu, J. T. & Yeh, T. S. 及其他11, , 2026, 於: Gastric Cancer. 29, 4, p. 681-701 21 p.研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審
開啟存取 -
A phase 1 study of fixed-dose regimens of serplulimab, an anti-PD-1 antibody, in patients with advanced solid tumors.
Ho, C. L., Chao, T. Y., Wu, S. Y., Chang, C. L., Lin, H. Y., Yang, F., Shen, Y., Yu, H. & Wang, Q., 6月 2025, 於: Journal of Clinical Oncology. 43, 16, p. 2596 1 p.研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審
資料集
-
MOESM1 of CSE1L, a Novel Microvesicle Membrane Protein, Mediates Ras-Triggered Microvesicle Generation and Metastasis of Tumor Cells
Lee, W.-R. (Contributor), Yeh, C.-M. (Creator), Lin, S.-H. (Creator), Yeh, K.-T. (Creator), Liao, C.-F. (Contributor), Jiang, M.-C. (Contributor), Chen, H.-C. (Creator), Chen, Y.-C. (Creator), Chang, C.-C. (Contributor), Luo, S.-F. (Contributor), Hsu, T.-H. (Contributor), Chiou, J.-F. (Contributor), Tai, C.-J. (Contributor), Shen, S.-C. (Contributor) & Li, L.-T. (Contributor), Figshare, 2012
DOI: 10.6084/m9.figshare.7103444.v1, https://doi.org/10.6084%2Fm9.figshare.7103444.v1
資料集: Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I.-C. (Contributor), Lai, G.-M. (Contributor), Chow, J.-M. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Li, C.-H. (Contributor), Yan, J.-L. (Contributor), Chuang, S.-E. (Contributor), Whang-Peng, J. (Creator), Bai, K.-J. (Contributor) & Yao, C.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
資料集: Dataset
-
Additional file 1: Figure S1. of Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction
Huang, J.-S. (Contributor), Yao, C.-J. (Contributor), Chuang, S.-E. (Contributor), Yeh, C.-T. (Contributor), Lee, L.-M. (Creator), Chen, R.-M. (Contributor), Chao, W.-J. (Contributor), Whang-Peng, J. (Creator) & Lai, G.-M. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3643112_d1.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_Figure_S1_of_Honokiol_inhibits_sphere_formation_and_xenograft_growth_of_oral_cancer_side_population_cells_accompanied_with_JAK_STAT_signaling_pathway_suppression_and_apoptosis_induction/4464386/1
資料集: Dataset